Thyrocare Q4 FY2026 profit after tax rises 128% to ₹48.7cr
NewsBytes | May 8, 2026 12:40 PM CST
Thyrocare processed 5.9cr tests this quarter
The company processed a massive 5.9 crore tests this quarter, a 29% increase, keeping Thyrocare at the top as India's largest test processor.
For the full year, it brought in ₹829 crore revenue (up 21%) and expanded its offerings with new allergy testing and noninvasive prenatal testing (NIPT).
CEO Rahul Guha credits its success to better operations, expanding into new regions, and focusing on specialty diagnostics, all while sticking to high-quality standards.
READ NEXT
-
Small acts, Big Impact: Why World Red Cross Day matters more than ever
-
'Dug Dug' review: A visually striking satire about holy motors and blind faith
-
Udupi Police launches 'Locked House Beat System' to prevent house thefts
-
This book records the Bhil tribes' resistance movements against Rajputs, Marathas and the British
-
US, Iran trade fire in West Asia, oil prices rise
